These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Proinflammatory and anti-inflammatory cytokine gene polymorphisms in hypersensitivity pneumonitis. Kondoh K; Usui Y; Ohtani Y; Inase N; Miyake S; Yoshizawa Y J Med Dent Sci; 2006 Mar; 53(1):75-83. PubMed ID: 16722148 [TBL] [Abstract][Full Text] [Related]
24. [Polymorphism of interleukin-10 gene promoter and its association with susceptibility to chronic obstructive pulmonary disease in Chinese Han people]. Hu RC; Xu YJ; Zhang ZX; Xie JG Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):504-7. PubMed ID: 14669219 [TBL] [Abstract][Full Text] [Related]
25. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency. Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780 [TBL] [Abstract][Full Text] [Related]
26. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700 [TBL] [Abstract][Full Text] [Related]
27. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer. Ahirwar D; Mandhani A; Mittal RD Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-10 promoter polymorphisms are associated with the mode and sequel of HBeAg seroconversion in patients with chronic hepatitis B virus infection. Peng XM; Huang YS; Ma HH; Gu L; Xie QF; Gao ZL Liver Int; 2006 Apr; 26(3):326-33. PubMed ID: 16584395 [TBL] [Abstract][Full Text] [Related]
30. Mannose-binding lectin gene polymorphisms are not associated with susceptibility to hepatitis C virus infection in the Brazilian Amazon region. Vallinoto AC; da Silva RF; Hermes RB; Amaral IS; Miranda EC; Barbosa MS; Moia Lde J; Conde SR; Soares Mdo C; Lemos JA; Machado LF; Ishak MO; Ishak R Hum Immunol; 2009 Sep; 70(9):754-7. PubMed ID: 19540295 [TBL] [Abstract][Full Text] [Related]
31. IL-10 polymorphisms and prostate cancer risk: a meta-analysis. Shao N; Xu B; Mi YY; Hua LX Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):129-35. PubMed ID: 21339768 [TBL] [Abstract][Full Text] [Related]
32. Association of the interleukin-10 -592A/C, -1082G/A and -819T/C gene polymorphisms with type 2 diabetes: a meta-analysis. Li J; Wu S; Wang MR; Wang TT; Zhu JM Gene; 2013 Jun; 521(2):211-6. PubMed ID: 23562725 [TBL] [Abstract][Full Text] [Related]
33. Association of functional polymorphism of ApoB promoter with hepatitis C virus infection. Zhu C; Zhang R; Liu D; Mukhtar MM; Liu W; Peng G; Wang K; Hao Q; Xu Y; Liu F; Zhu Y; Wu J Clin Chim Acta; 2009 Mar; 401(1-2):124-7. PubMed ID: 19083997 [TBL] [Abstract][Full Text] [Related]
34. [A meta-analysis on interleukin-1 gene cluster polymorphism and genetic susceptibility for ankylosing spondylitis]. Wu Z; Gu JR Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):433-7. PubMed ID: 17459217 [TBL] [Abstract][Full Text] [Related]
36. Association of interleukin-18 gene polymorphism (-607A/A genotype) with susceptibility to chronic hepatitis B virus infection. Hirankarn N; Manonom C; Tangkijvanich P; Poovorawan Y Tissue Antigens; 2007 Aug; 70(2):160-3. PubMed ID: 17610422 [TBL] [Abstract][Full Text] [Related]
37. Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection. Ferré N; Marsillach J; Camps J; Rull A; Coll B; Tous M; Joven J Clin Chim Acta; 2005 Nov; 361(1-2):206-10. PubMed ID: 15993873 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma. Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576 [TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease. Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365 [TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Peng B; Cao L; Ma X; Wang W; Wang D; Yu L Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]